LB PHARMACEUTICALS INC

Historical 13F Holders

Symbol
LBRX
CUSIP
50180M108
All holders as of
Q3 2026
Type
Equity
Class
COM SHS
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 50180M108 since 12/18/2024, largest first.

Filer % of Class Filed
Deep Track Capital, LP 13D/A
11.7% 2/10/2026
Event 2/6/2025
RA Capital Management, L.P. 13G/A
8.7% 2/17/2026
Event 12/31/2025
BlackRock, Inc. 13G/A 6.3% 7/29/2026
Event 6/30/2026
Pontifax Management 4 G.P. (2015) Ltd. 13D
6.3% 9/25/2025
Event 9/12/2025
Commodore Capital LP 13G/A
5.8% 11/16/2026
Event 9/30/2026
Caligan Partners LP 13G
5.0% 5/15/2026
Event 3/31/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
JPMorgan Chase & Co 13G/A 4.3% 10/13/2026
Event 9/30/2026
BlackRock Portfolio Management LLC 13G/A 3.8% 1/21/2026
Event 12/31/2025
Trails Edge Capital Partners, LP 13G/A
3.6% 11/16/2026
Event 9/30/2026
TCG Crossover GP II, LLC 13G/A
2.4% 11/16/2026
Event 9/30/2026

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 148 34.1 M $1.30B
2026 Q2 114 29.8 M $966M
2026 Q1 77 28.2 M $692M
2025 Q4 68 24.8 M $552M
2025 Q3 54 20.0 M $315M